A Cambridge-based therapeutics company is working on a gene therapy aimed at a key protein in the eye that it says will help older adults against macular degeneration
Researchers unveil pioneering approach to combat age-related vision loss
June 5, 2024 (Cambridge, MA) – Cirrus Therapeutics, the University of Bristol, and London’s Global University Institute of Ophthalmology have discovered a revolutionary treatment for age-related macular degeneration (AMD), the leading cause of vision loss among older adults. Featured on the cover of the journal Science Translational Medicine, this breakthrough research reveals that boosting a specific protein, […]
Researchers unveil pioneering approach to combat age-related vision loss
Working together towards common goals strengthens bonds among community members.
Boosting Key Protein in Eye Cells Shows Promise in preventing AMD
Increasing the levels of a key protein in eye cells may help protect against age-related macular degeneration (AMD), according to new research led by the University of Bristol.
Replenishing IRAK-M expression in retinal pigment epithelium attenuates outer retinal degeneration
Chronic inflammation is a constitutive component of many age-related diseases, including age-related macular degeneration (AMD). Here, we identified interleukin-1 receptor–associated kinase M (IRAK…